Skip to search boxSkip to navigationSkip to main content

The molar ratio of σ73 to core polymerase in the obligate intracellular bacterium, Rickettsia prowazekii

  • Han‐Fei ‐F Ding
    ,
  • Herbert H. Winkler(corresponding author)
*Corresponding author for this work
  • University of South Alabama
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

In the obligate Intracellular parasitic bacterium, Rickettsia prowazekii, the molar ratio of σ73 to core RNA polymerase, that is, the degree of saturation of the core polymerase by the catalytically active sigma factor, was very low. This ratio was determined from the radioactivity in rickettsial RNA polymerase immuno‐precipitated from crude extracts of infected L929 cells in which the parasite was exponentially growing. If we assume that, as Is true for the σ subunit, in R. prowazekii and Escherichia coli the β’and β subunits of the RNA polymerase have similar methionine and cysteine contents (the radiolabelled amino acids), the molar ratio of σ73 to core polymerase in R prowazekii would be 0.1. This is in striking contrast to E. Coli where the ratio is typically 0.4. it remains to be established whether this low sigma saturation results In a limitation of active RNA polymerase in R. prowazekii and contributes to its slow growth.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 869-873 (5 pages)

Journal (Volume, Issue Number)

Molecular Microbiology (Volume 11, Issue 5)

Publication milestones

  • Published - 03/1994

Publication status

Published - 03/1994

ISSN

0950-382X

Publication IDs

  • Scopus: 0028181482
  • PubMed: 8022263
  • ORCID: /0000-0001-5702-3439/work/67683747

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
5
Captures
4

Funding Details

FunderFunding number
NIAID
R01AI015035